Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 USD | -3.74% |
|
+9.69% | -58.84% |
06-20 | SAB Biotherapeutics, Inc. has Changed its Name to SAB BIO | CI |
06-07 | Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SAB BIOTHERAPEUTICS, INC. | Bio Therapeutic Drugs | -3.74% | +9.69% | -58.84% | -62.27% | - | 26.12M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- SABS Stock
- Charts SAB Biotherapeutics, Inc.
- Relative Strength Chart